Advert on Bio2Business

 


INDENA CDMO - HPAPI , New Chemical Entity , ADC Drug-Linker

Headquartered in Milan (Italy), Indena is the leading company dedicated to the identification, development and production of high quality active principles for use in the pharmaceutical industry. Backed up by a century of experience, 4 production sites and over 1000 high-skilled staff, the company invested a significant amount of its annual turnover in research and technological expansions, making CDMO activities the key to its success and a priority in Indena’s strategic vision. Custom services and strong partnerships with clients have been a company focus since the very beginning and, thanks to a meticulous activity done over the last 30 years, nowadays those represent one of the Indena’s key strengths. Today, Indena manufactures 12 commercial HPAPIs from different origin: synthetic, semi-synthetic and fermentation molecules. This positioning has been achieved thanks to Indena capacity to handle HPAPI with an OEL from 1 Microgram /m3 to 20 ng/m3.

Type: Commercial Update

Category: CMC: Small Molecules, Drug Substance
CMC: Small Molecules, Analytical

Hashtags: #adc, #api, #cdmo, #cdmosmallmoleculeadc, #customsynthesis, #fda, #gmp, #hpapi, #payload, #smallmolecule